[Skip to Content]
[Skip to Content Landing]
Views 144
Citations 0
From JAMA's Daily News Site
October 16, 2013

From JAMA’s Daily News Site

JAMA. 2013;310(15):1550. doi:10.1001/jama.2013.280006

Survival rates for US patients with HIV and AIDS who develop lymphoma appear stagnant, even in the era of antiretroviral therapy (ART).

Data from 476 patients treated for HIV infection and lymphoma at 8 US sites showed shifting trends in HIV-related lymphoma between 1996, when ART was introduced, and 2010. Patients’ average age increased, the proportion of Latino patients increased, and patients had improved health indicators—lower levels of HIV in their blood and higher numbers of CD4 T cells, the immune cell that HIV attacks. But no significant survival improvements emerged during the 14-year study period.